Paul F. Schellhammer Lecture

In 2011, the Mid-Atlantic Section developed the Paul Schellhammer Lecture in Urologic Oncology to be presented annually to Section membership at the Annual Meetings in order to honor Dr. Schellhammer. Dr. Paul F. Schellhammer is a devoted member and Past President of the MA-AUA and AUA. Contributions to this fund go to hosting future speakers for the Schellhammer Lecture.

2024
Michael Cookson, MD – University of Oklahoma Health Sciences Center Oklahoma City, OK
Management of High Risk and Advanced Prostate Cancer: Back to the Future

2023
Glenn Preminger, MD – Duke University, Durham, NC
Evolution of Stone Management

2022
Mark S. Litwin, MD, MPH – David Geffen School of Medicine, Los Angeles, CA
Evolution of Health Services Research in Urology

2021
Jeffrey Cadeddu, MD – Texas Southwestern Medical Center, Dallas, TX
Multiparametric MRI to Evaluate Renal Masses – Virtual Biopsy

2020
Matthew Cooperburg, MD – University of California, San Francisco, CA
Big Data and Prostate Cancer

2019
Peter Pinto, MD – National Cancer Institute, Bethesda, MD
Prostate Cancer Imaging for Urologists: A Bench to Bedside Story

2018
Ian Thompson, MD – CHRISTUS Santa Rosa Hospital, San Antonio, TX
Updated, Long-Term Results of the Prostate Cancer Prevention Trial: Impact on Seven Years of Finasteride on Risk of Cancer and Risk of Prostate Cancer Death.

2017
Daniel Lin, MD – University of Washington, Seattle, WA
High Risk Prostate Cancer: Contemporary Treatment Paradigms, Outcomes and Future Directions

2016
Charles G. Drake MD, PhD  – Johns Hopkins University, Baltimore, MD
Immunotherapy in GU Cancers – An Overview

2015
Robert C. Flanigan, MD – Loyola University, Maywood, IL
Renal Cell Cancer 

2014
Michael Droller, MD – Mt Sinai Hospital, New York, NY
Considerations in the Pathogenesis of Bladder Cancer in Assessment and Treatment

2013
Ronald Lee Hrebinko, MD – University of Pittsburgh Physicians, Pittsburgh, PA
In Search of the Perfect Partial Nephrectomy…(or the Ramblings of a Urological Curmudgeon)

2012
Harry W. Herr, MD – Memorial Sloan-Kettering Cancer Center, New York, NY
Optimal Therapy for Muscle-Invasive Bladder Cancer-History, Evidence and the Robot

2011
Paul H. Lange, MD – University of Washington School of Medicine, Seattle, WA
Some Possibly Heretical Observations about Local Control and New Therapies in Prostate Cancer